Table 2.
Prevalence of main clinical manifestations in MMF patients in published series.
| Reference | No. of patients | Myalgias (%) | Arthralgias (%) | Cognitive disturbances (%) | Psychiatric manifestations | Other |
|---|---|---|---|---|---|---|
| (1) | 14 | 86 | 64 | – | – | Weakness 43% |
| Fever 28% | ||||||
| Dyspnea 21% | ||||||
| (21) | 12 | 92 | 58 | – | – | Weakness 42% |
| Fever 17% | ||||||
| Spinal pain 17% | ||||||
| (22) | 7 | 86 | 14 | 14 | 14 | Multiple sclerosis (MS) 100% |
| (2) | 50 | 94 | – | – | – | Autoimmune diseases 34% (MS 12%) |
| (23, 24) | 10 | 60 | 30 | 20 | – | |
| (25) | 30 | 87 | 57 | 50 | 50 | Chronic fatigue syndrome 53% |
| (12) | 30 | 88 | 57 | 50 | 53 | Autoimmune diseases 19% |
| (26) | 9 | 55 | – | – | – | Neurological signs 44% |
| (5) | 25 | 96 | 84 | 68 (Patients statement) | 52 | Cognitive dysfunction 100% |
| (27) | 16 | 56 | 12.5 | – | – | Chronic fatigue syndrome 50% |
| (18) | 53 | 81 | 57 | – | – | Headache 28% |
| Dyspnea 27% | ||||||
| (19) | 28 | 81 | 50 | – | – |